Valuations for the sector are, by and large, not expensive but not cheap either. In some cases, it is close to the long-term averages and should be evaluated case by case.

Atul: Why investors should turn cautious

High-cost inventory of raw materials is a key worry when global growth is faltering

Atul: Focus is on enhancing vertical integration

Notwithstanding operational headwinds and higher working capital, Atul remains on track for a three-year capex cycle

Atul: Proxy for global recovery

We believe that even if the domestic equity market underperforms global indices, the Indian chemicals sector should be resilient in the near- to medium-term. Atul is one of the preferred proxies to play this theme

Atul and Amal: When basic chemicals get special

Basic chemical player Amal warrants investors’ attention just as APIs in the pharma space are getting policy attention

Atul Q2: Exceptional show by performance chemicals

For global MNCs, the current crisis adds to the growing theme of sourcing chemicals from India as an alternative. Atul industries is a clear favourite in this scheme of things

Atul Q1: Pharma and agrochem cushion the Covid impact

Atul Industries is better positioned to deal with near-term hurdles with respect to operations, supply chain and working capital management

Amid midcap carnage, these 3 companies posted stellar earnings in Q1

Investors need to be mindful of volatility in the midcap space and should capitalise on the weakness